Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
129,668,560
-
Total 13F shares
-
117,343,229
-
Share change
-
+5,977,220
-
Total reported value
-
$956,378,739
-
Put/Call ratio
-
33%
-
Price per share
-
$8.15
-
Number of holders
-
222
-
Value change
-
+$558,727
-
Number of buys
-
114
-
Number of sells
-
127
Institutional Holders of NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) as of Q2 2022
As of 30 Jun 2022,
NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) was held by
222 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
117,343,229 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BROWN ADVISORY INC, STATE STREET CORP, Assenagon Asset Management S.A., GOLDMAN SACHS GROUP INC, First Light Asset Management, LLC, FEDERATED HERMES, INC., and SCHRODER INVESTMENT MANAGEMENT GROUP.
This page lists
222
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.